Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(pheochromocytoma)
22,130 results
  • PDQ Cancer Information Summaries: Unusual Cancers of Childhood Treatment (PDQ®): Health Professional Version [BOOK]
    National Cancer Institute (US): Bethesda (MD) PDQ Pediatric Treatment Editorial Board BOOK
  • This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of unusual cancers of childhood. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. This summary is reviewed regularly an…
  • PDQ Cancer Information Summaries: Unusual Cancers of Childhood Treatment (PDQ®): Patient Version [BOOK]
    National Cancer Institute (US): Bethesda (MD) PDQ Pediatric Treatment Editorial Board BOOK
  • This PDQ cancer information summary has current information about the treatment of unusual cancers of childhood. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care. Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in …
  • Metastatic pheochromocytoma and paraganglioma: proceedings of the MEN2019 workshop. [Review]
    Endocr Relat Cancer 2020Dahia P, Clifton-Bligh R, … Jimenez C
  • Pheochromocytomas and paragangliomas (PPGLs) are adrenal or extra-adrenal autonomous nervous system-derived tumors. Most PPGLs are benign, but approximately 15% progress with metastases (mPPGLs). mPPGLs are more likely to occur in patients with large pheochromocytomas, sympathetic paragangliomas and norepinephrine-secreting tumors. Older subjects, those with larger tumors and synchronous metastas…
  • Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents. [Journal Article]
    J Cancer Res Clin Oncol 2020Jochmanova I, Abcede AMT, … Pacak K
  • CONCLUSIONS: The present report has highlighted several important aspects in the management of pediatric patients with SDHB mutations associated-PHEO/PGL. Initial diagnostic evaluation of SDHB mutation carriers should be started at age of 5-6 years with initial work-up focusing on abdominal region. Thorough follow-up is crucial first 2 years post-diagnosis and more frequent follow-ups are needed in years 10-20 post-diagnosis due to the increased risk of metastases. Although this age group developed metastasis as early as 5 years from diagnosis, we have shown that the overall 20-year prognosis and survival are good.
New Search Next